86 related articles for article (PubMed ID: 15723165)
1. The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.
Atwood CS; Bowen RL
Horm Behav; 2015 Nov; 76():63-80. PubMed ID: 26188949
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection.
Webber KM; Bowen R; Casadesus G; Perry G; Atwood CS; Smith MA
Acta Neurobiol Exp (Wars); 2004; 64(1):113-8. PubMed ID: 15190686
[TBL] [Abstract][Full Text] [Related]
3. Gene-Dose-Dependent Reduction Fshr Expression Improves Spatial Memory Deficits in Alzheimer's Mice.
Frolinger T; Korkmaz F; Sims S; Sen F; Sultana F; Laurencin V; Cullen L; Pallapati AR; Liu A; Rojekar S; Pevnev G; Cheliadinova U; Vasilyeva D; Burganova G; Macdonald A; Saxena M; Goosens K; Rosen C; Barak O; Lizneva D; Gumerova A; Ye K; Ryu V; Yuen T; Zaidi M
Res Sq; 2024 Feb; ():. PubMed ID: 38463956
[TBL] [Abstract][Full Text] [Related]
4. Symptoms of menopause - global prevalence, physiology and implications.
Monteleone P; Mascagni G; Giannini A; Genazzani AR; Simoncini T
Nat Rev Endocrinol; 2018 Apr; 14(4):199-215. PubMed ID: 29393299
[TBL] [Abstract][Full Text] [Related]
5. Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer's disease.
Mayburd A; Baranova A
BMC Syst Biol; 2013 Nov; 7():121. PubMed ID: 24196233
[TBL] [Abstract][Full Text] [Related]
6. Structure, function and regulation of gonadotropin receptors - a perspective.
Menon KM; Menon B
Mol Cell Endocrinol; 2012 Jun; 356(1-2):88-97. PubMed ID: 22342845
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure.
Carroll JC; Rosario ER; Kreimer S; Villamagna A; Gentzschein E; Stanczyk FZ; Pike CJ
Brain Res; 2010 Dec; 1366():233-45. PubMed ID: 20934413
[TBL] [Abstract][Full Text] [Related]
8. The X-chromosome instability phenotype in Alzheimer's disease: a clinical sign of accelerating aging?
Bajić VP; Spremo-Potparević B; Zivković L; Bonda DJ; Siedlak SL; Casadesus G; Lee HG; Smith MA
Med Hypotheses; 2009 Dec; 73(6):917-20. PubMed ID: 19647374
[TBL] [Abstract][Full Text] [Related]
9. Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.
Braverman ER; Chen TJ; Prihoda TJ; Sonntag W; Meshkin B; Downs BW; Mengucci JF; Blum SH; Notaro A; Arcuri V; Varshavskiy M; Blum K
Age (Dordr); 2007 Sep; 29(2-3):55-67. PubMed ID: 19424831
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant therapy in Alzheimer's disease: theory and practice.
Aliev G; Obrenovich ME; Reddy VP; Shenk JC; Moreira PI; Nunomura A; Zhu X; Smith MA; Perry G
Mini Rev Med Chem; 2008 Nov; 8(13):1395-406. PubMed ID: 18991755
[TBL] [Abstract][Full Text] [Related]
11. Androgen cell signaling pathways involved in neuroprotective actions.
Pike CJ; Nguyen TV; Ramsden M; Yao M; Murphy MP; Rosario ER
Horm Behav; 2008 May; 53(5):693-705. PubMed ID: 18222446
[TBL] [Abstract][Full Text] [Related]
12. Hormonal and morphological study of the pituitaries in reeler mice.
Lombardero M; Kovacs K; Horvath E; Salazar I
Int J Exp Pathol; 2007 Jun; 88(3):165-73. PubMed ID: 17504446
[TBL] [Abstract][Full Text] [Related]
13. Targeting gonadotropins: an alternative option for Alzheimer disease treatment.
Casadesus G; Puig ER; Webber KM; Atwood CS; Escuer MC; Bowen RL; Perry G; Smith MA
J Biomed Biotechnol; 2006; 2006(3):39508. PubMed ID: 17047306
[TBL] [Abstract][Full Text] [Related]
14. The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.
Barron AM; Verdile G; Martins RN
Endocrine; 2006 Apr; 29(2):257-69. PubMed ID: 16785601
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the role of gonadotropin hormones in the development of Alzheimer disease.
Casadesus G; Atwood CS; Zhu X; Hartzler AW; Webber KM; Perry G; Bowen RL; Smith MA
Cell Mol Life Sci; 2005 Feb; 62(3):293-8. PubMed ID: 15723165
[TBL] [Abstract][Full Text] [Related]
16. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.
Casadesus G; Garrett MR; Webber KM; Hartzler AW; Atwood CS; Perry G; Bowen RL; Smith MA
Drugs R D; 2006; 7(3):187-93. PubMed ID: 16752944
[TBL] [Abstract][Full Text] [Related]
17. Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease.
Casadesus G; Zhu X; Atwood CS; Webber KM; Perry G; Bowen RL; Smith MA
Curr Drug Targets CNS Neurol Disord; 2004 Aug; 3(4):281-5. PubMed ID: 15379604
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Luteinizing Hormone in Alzheimer Disease Development in Elderly Women.
Rao CV
Reprod Sci; 2017 Mar; 24(3):355-368. PubMed ID: 27436369
[TBL] [Abstract][Full Text] [Related]
19. The gonadotropin connection in Alzheimer's disease.
Meethal SV; Smith MA; Bowen RL; Atwood CS
Endocrine; 2005 Apr; 26(3):317-26. PubMed ID: 16034187
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
